Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
EV to Sales History
Trending higher.
Left:
||||
Enterprise value to sales ratio
Latest
229.65
Near historical average
Average (9y)
213.93
Historical baseline
Range
High:670.57
Low:-10.70
CAGR
-2.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 229.65 | +140.4% |
| 2023 | 95.52 | -22.2% |
| 2022 | 122.82 | -80.5% |
| 2021 | 628.82 | -6.2% |
| 2020 | 670.57 | +15556.7% |
| 2019 | -4.34 | +59.4% |
| 2018 | -10.70 | -240.1% |
| 2017 | 7.64 | -93.1% |
| 2016 | 110.26 | -61.9% |
| 2015 | 289.04 | - |